NEWS / IR
-
2024. 03. 15EVENTCellusion CEO Shin Hatou will speak on “Research and development of new corneal regenerative medicine using iPS cells” at the Minaris Regenerative Medicine’s luncheon seminar at the 23rd Congress of the Japanese Society for Regenerative Medicine on March 23, 2024.
-
2024. 02. 29IRCellusion Director and Executive Appointments
-
2024. 01. 29NEWSAnnouncement of Head Quarters Relocation
and Establishment of New Laboratory -
2023. 12. 22IRCellusion Receives U.S. FDA Orphan Drug Designation for CLS001
-
2023. 12. 14NEWSCellusion CEO, Dr. Shin Hatou received the METI Minister’s Award at the 23rd Japan Venture Awards
-
2023. 12. 12IRAnnouncement on Appointment of Officers
-
2023. 12. 01IRCellusion has been selected for the AMED subsidy program
-
2023. 11. 28IRThe core technology patent for Cellusion’s development product CLS001,
“METHOD FOR DERIVING CORNEAL ENDOTHELIUM REPLACEMENT CELLS FROM IPS CELLS” was granted in Japan -
2023. 11. 27EVENTCellusion will exhibit at “Genesis 2023” in London
-
2023. 11. 08EVENTCellusion CFO Takuya Kaneko will join the “GROWTH INDUSTRY CONFERENCE 2023” pitch contest on November 16.
![](/assets/img/news/ft_img_sp.jpg)